Wolverine Trading, LLC Axsome Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$78.93 - $95.84 $1 Million - $1.22 Million	12,700 Added 62.56%	33,000 $2.97 Million
Q2 2024 Aug 14, 2024	BUY	$65.72 - $80.5 $295,740 - $362,250	4,500 Added 28.48%	20,300 $1.63 Million
Q1 2024 May 15, 2024	SELL	$69.39 - $97.64 $666,144 - $937,344	-9,600 Reduced 37.8%	15,800 $1.26 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $534,006 - $777,573	9,300 Added 57.76%	25,400 $2.02 Million
Q3 2023 Nov 15, 2023	SELL	$69.25 - $82.21 $685,575 - $813,878	-9,900 Reduced 38.08%	16,100 $1.13 Million
Q2 2023 Aug 23, 2023	SELL	$58.41 - $90.35 $245,322 - $379,470	-4,200 Reduced 13.91%	26,000 $1.87 Million
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $105,102 - $135,000	-1,800 Reduced 5.63%	30,200 $1.83 Million
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $271,592 - $542,096	6,800 Added 26.98%	32,000 $2.47 Million
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $908,712 - $1.76 Million	25,200 New	25,200 $1.11 Million

328

37.8M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.42B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.